聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 22 分钟 17 秒 前

Catalyst Pharmaceuticals Announces Reduction in Workforce as Part of Operating Expense Management Plan

周二, 05/17/2016 - 13:41
CORAL GABLES, Fla., May 17, 2016 -- (Healthcare Sales & Marketing Network) -- Catalyst Pharmaceuticals, Inc. (CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, toda...
Biopharmaceuticals
Catalyst Pharmaceuticals, Firdapse

Mesa Biotech Announces Key Additions to Executive Management Team

周二, 05/17/2016 - 13:34
Tom Willardson and John Monroe Join Mesa Biotech's Leadership SAN DIEGO, May 17, 2016 -- (Healthcare Sales & Marketing Network) -- Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed a testing platform designed specific...
Diagnostics, Personnel
Mesa Biotech, assay-specific test cassette

Lightpoint Medical Announces Exclusive Global License Agreement With the University of Arizona to Develop Molecular Imaging Technology

周二, 05/17/2016 - 13:28
CHESHAM, England, May 17, 2016 -- (Healthcare Sales & Marketing Network) -- Lightpoint Medical, a clinical-stage medical device company developing advanced imaging technologies for intraoperative cancer detection, announced today that the company has sign...
Devices, Radiology, Licensing
Lightpoint Medical, Beta Emission Tomography, imaging

Nouscom Concludes Successful Series A Financing of EUR 12 Million

周二, 05/17/2016 - 13:20
BASEL, Switzerland, May 17, 2016 -- (Healthcare Sales & Marketing Network) -- Nouscom announced today that it has closed a EUR 12 million Series A financing co-led by LSP and Versant Ventures. The funds will be used to support discovery and development of...
Biopharmaceuticals, Oncology, Venture Capital
Nouscom, personalized cancer vaccine

Leeds St James Acquires Eight Elekta Linear Accelerators for Advanced Cancer Treatment

周二, 05/17/2016 - 13:12
LEEDS, UK--(Healthcare Sales & Marketing Network)--Leeds Cancer Centre, one of the largest providers of cancer care in the UK, will upgrade its existing treatment equipment with eight Elekta (EKTA-B.ST) Versa HD™ linear accelerators. This replacement will ...
Devices, Oncology
Elekta, Versa HD, linear accelerator, radiotherapy

Orthofix Announces 510(k) Clearance and US Limited Market Launch of FORZA PTC Interbody Spacer System

周一, 05/16/2016 - 21:47
LEWISVILLE, Texas--(Healthcare Sales & Marketing Network)--Orthofix International N.V. (OFIX), a diversified, global medical device company, today announced the 510(k) clearance and U.S. limited market launch of the FORZA® PTC™ (Peek Titanium Composite...
Devices, Orthopaedic, Neurosurgery, FDA
Orthofix International, FORZA PTC, interbody spacers, spine surgery

Zimmer Biomet Completes Acquisition of Cayenne Medical

周一, 05/16/2016 - 14:52
WARSAW, Ind., May 16, 2016 -- (Healthcare Sales & Marketing Network) -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced today the completion of its previously announced acquisition of Scottsdale, ...
Devices, Orthopaedic, Mergers & Acquisitions
Zimmer Biomet, Cayenne Medical

Caribou Biosciences Raises $30 Million in Series B Funding

周一, 05/16/2016 - 14:40
BERKELEY, Calif.--(Healthcare Sales & Marketing Network)--Caribou Biosciences, Inc., a developer of CRISPR-Cas technologies for genome engineering, today announced the completion of a $30 million Series B financing round. The financing included the partici...
Biopharmaceuticals, Venture Capital, Personnel
Caribou Biosciences, CRISPR-Cas

Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear Neurostimulator

周一, 05/16/2016 - 13:49
Two pivotal trials of Oculeve Intranasal Tear Neurostimulator met primary, secondary endpoints First and only neurostimulation device for increasing tear production in dry eye disease -- FDA submission on-track for second half of 2016 DUBLIN, May ...
Devices, Ophthalmology
Allergan, Oculeve, Intranasal Tear Neurostimulator, Dry Eye Disease

The Medicines Company Appoints Tony Kingsley as President and Chief Operating Officer

周一, 05/16/2016 - 13:44
PARSIPPANY, N.J.--(Healthcare Sales & Marketing Network)--The Medicines Company (MDCO) has announced the appointment of Tony Kingsley as President and Chief Operating Officer. Mr. Kingsley will help oversee the day-to-day operations of the company and will...
Biopharmaceuticals, Personnel
The Medicines Company

Pfizer to Acquire Anacor

周一, 05/16/2016 - 13:38
Strong fit with Pfizer’s Inflammation and Immunology portfolio Expected to enhance near-term revenue growth for the innovative business Anacor’s flagship asset, crisaborole, has a New Drug Application under review by the U.S. Food and Drug Administra...
Biopharmaceuticals, Mergers & Acquisitions
Pfizer, Anacor, crisaborole, PDE4 inhibitor

Luminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc.

周一, 05/16/2016 - 13:29
Acquisition Creates Premier Portfolio of Molecular Testing Solutions Expands Access to the High-Growth Molecular Microbiology Market Immediately Accelerates Growth, Accretive to Adjusted Earnings by End of 2017 AUSTIN, Texas and NORTHBROOK, Ill., ...
Diagnostics, Mergers & Acquisitions
Luminex, Nanosphere

Neos Therapeutics Announces U.S. Launch of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients Six Years and Older

周一, 05/16/2016 - 13:20
DALLAS and FORT WORTH, Texas, May 16, 2016 -- (Healthcare Sales & Marketing Network) -- Neos Therapeutics, Inc. (NEOS), a pharmaceutical company with a late-stage pipeline of innovative extended-release (XR) product candidates for the treatment of attentio...
Biopharmaceuticals, Product Launch
Neos Therapeutics, ADHD, Adzenys XR-ODT

Impulse Dynamics Completes $30 Million Financing Round

周五, 05/13/2016 - 16:30
MT. LAUREL, New Jersey, May 13, 2016 -- (Healthcare Sales & Marketing Network) -- Impulse Dynamics, developer of the Optimizer™ IVs implantable device for treatment of chronic heart failure (CHF), announced today that the company has closed a $30 million ...
Devices, Cardiology, Venture Capital
Impulse Dynamics, Optimizer, heart failure

STAAR Surgical Announces Approval By Health Canada of Its EVO Visian ICL(TM) for Surgeons and Their Patients in Canada

周五, 05/13/2016 - 13:51
MONROVIA, Calif., May 13, 2016 -- (Healthcare Sales & Marketing Network) -- STAAR Surgical Company (STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, was notified yesterday of the appro...
Devices, Ophthalmology, Regulatory
STAAR Surgical, EVO Visian ICL, Collamer Lens

Boston Scientific Announces Schedule of Presentations at EuroPCR 2016

周五, 05/13/2016 - 13:42
MARLBOROUGH, Mass., May 13, 2016 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (BSX) today announced the schedule of key data that will be featured at the annual EuroPCR Scientific Program, May 17-20 in Paris. Data from the 1,000-patie...
Devices, Interventional, Cardiology
Boston Scientific, EuroPCR, WATCHMAN, Lotus, SYNERGY

WaferGen Bio-systems and Takara Bio Inc. Announce Merger Agreement

周五, 05/13/2016 - 13:35
Transaction scheduled to close following completion of the 2016 fiscal year FREMONT, Calif. and MOUNTAIN VIEW, Calif., May 13, 2016 -- (Healthcare Sales & Marketing Network) -- WaferGen Bio-systems, Inc. (WGBS), a publicly held genomics technology comp...
Diagnostics, Mergers & Acquisitions
WaferGen Bio-systems, Takara Bio USA Holdings

Alprolix(R) (rFIXFc) approved in the EU for the treatment of haemophilia B

周五, 05/13/2016 - 13:29
First Fc Fusion therapy approved for haemophilia B in the EU to provide extended protection against bleeds STOCKHOLM--(Healthcare Sales & Marketing Network)--Swedish Orphan Biovitrum AB (publ) (http://www.sobi.com/) (Sobi™) (SOBI.ST) and Biogen (http://...
Biopharmaceuticals, Regulatory
Swedish Orphan Biovitrum, Sobi, Biogen, Alprolix, haemophilia B, hemophilia B

Cardiome Announces the Launch of ESMOCARD Solution for Injection in France

周四, 05/12/2016 - 13:57
VANCOUVER, May 12, 2016 -- (Healthcare Sales & Marketing Network) - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that ESMOCARD® (esmolol hydrochloride) 100mg/10ml solution for injection has been commercialized by its subsidiary and ...
Biopharmaceuticals, Cardiology, Product Launch
Cardiome Pharma, OP Orphan Pharma, ESMOCARD

Accera Completes Enrollment of Phase 3 NOURISH AD Study of AC-1204 for the Treatment of Alzheimer's Disease

周四, 05/12/2016 - 13:51
Top-Line Data Expected in December 2016 BOULDER, Colo., May 12, 2016 -- (Healthcare Sales & Marketing Network) -- Accera, Inc. today announced that it has completed enrollment of the NOURISH AD Phase 3 clinical study of AC-1204 for the treatment of mil...
Biopharmaceuticals, Neurology
Accera , NOURISH AD, Alzheimer's disease

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong